1/107
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
Learning
acquiring new information or skills
Memory
storing and retrieving that information later.
Classical conditioning
stimulus-stimulus learning (what predicts what).
Operant conditioning
behavior-consequence learning (what happens when I do this).
Flow of info through memory
Sensory memory, short-term/working memory, long-term memory (via encoding).
Short-term memory
brief storage of information.
Working memory
short-term storage plus manipulation of info.
Working memory capacity
5-9 items, varies with attention
Chunking
grouping items to increase memory capacity
Primacy effect
better memory for items at the start of a sequence
Recency effect
better memory for items at the end of sequences
Types of long-term memory
declarative, non-declarative
Declarative memory
facts/events (semantic vs episodic).
Non-declarative memory
skills, habits, conditioning, priming.
Hippocampus (role in memory)
Critical for forming new declarative and spatial memories.
HM showed that . . .
Hippocampus is needed for new episodic and semantic memories, and spatial memory; not required for old memories or procedural skills.
Trisynaptic circuit
The three-step excitatory pathway inside the hippocampus that supports memory formation
Trisynaptic circuit (steps in order)
DG, CA3, CA1
Hippocampus' role in spatial memory
Place cells in the hippocampus map memories of physical spaces.
Engram
The physical/biological trace of a memory in the brain.
PFC role in memory
Supports working memory, planning, and retrieval strategies.
Striatum role in memory
Procedural/habit learning and habit formation.
Amygdala (role)
fear
Anterior cingulate cortex
part of medial frontal cortex responsible for attention, error monitoring, emotion regulation in memory.
Hebbian synapse
"Cells that fire together wire together"—synapse strengthened by repeated co-activation.
Long-term potentiation (LTP)
Long-lasting strengthening of synapses following high stimulation.
Steps of LTP + key mechanisms
Glutamate binds AMPA/NMDA, NMDA opens after depolarization, Ca²⁺ influx, Ca²⁺ activates kinases, more AMPA receptors inserted.
Post-synaptic effect of LTP
more AMPA receptors, larger spine.
Pre-synaptic effect of LTP
increased glutamate release probability.
Korsakoff's syndrome
Severe anterograde/retrograde amnesia from thiamine deficiency (often alcoholism); damage to thalamus & mammillary bodies.
Alzheimer's disease
Progressive memory loss; associated with β-amyloid plaques, tau tangles, cell death, especially in hippocampus.
Role of ANS in emotion
changes (HR, BP, sweating) accompany and help shape emotional experience.
James-Lange theory
Emotion = brain's interpretation of bodily responses.
Cannon-Bard theory
Emotion and bodily responses occur simultaneously, independently.
Schachter-Singer theory (Two-factor)
Emotion = physiological arousal + cognitive interpretation.
Basic emotion theory
a few preset categories of emotions are innate in all humans
Core emotions (basic emotion theory)
happiness, sadness, anger, fear, disgust, surprise.
Evidence for basic emotion theory
specific brain regions activated for specific emotions (amygdala/fear, insula/disgust, etc.)
Theory of constructed emotion
Emotions built by brain from context, signals, past experiences, no fixed circuits
Evidence for constructed emotion theory
the same brain region can be active across many emotions, context changes labeling of arousal.
Basolateral (amygdala subregion)
learning emotional significance.
Central nucleus (amygdala subregion)
autonomic & behavioral responses.
Medial (amygdala subregion)
social/olfactory emotional info.
Damage to amygdala causes . . .
reduced fear, impaired fear learning, poor threat detection.
Amygdala connections
hippocampus (emotion + memory), hypothalamus (autonomic), PFC (regulation)
Key features of anxiety disorders
excessive fear, worry, avoidance, physical symptoms.
GAD (generalized anxiety disorder)
chronic worry, tension.
Panic disorder
sudden panic attacks.
Phobia
intense fear of specific object/situation.
PTSD
trauma-related intrusion, avoidance, arousal.
OCD
intrusive thoughts + compulsions.
General neurobiology of anxiety
Hyperactive amygdala, hypoactive PFC, altered serotonin, GABA, and HPA axis regulation.
Acoustic startle (animal research)
measures fear reactivity.
Open field (animal research)
measuresanxiety (avoid center).
Elevated plus maze (animal research)
avoid open arms = anxiety.
Light-dark box (animal research)
avoid light = measures anxiety.
Benzodiazepines
enhance GABA affects, reduce anxiety.
SSRIs
increase serotonin over time, reduce anxiety
Tricyclics
Prevent reuptake of serotonin and norepenephirine, reduce anxiety
MAOIs
blockbreakdown of NTs like serotonin, dopamine, and norepinephrine, reduce anxiety
Psychedelics
psilocybin, MDMA (experimental) may decrease anxiety via emotional processing + neuroplasticity, potentially reduce anxiety
Stress & general adaptation syndrome
Alarm, resistance, exhaustion.
HPA axis is
the brain's major stress response system
HPA axis path
Hypothalamus (CRH), Pituitary (ACTH), Adrenal cortex (cortisol).
Acute stress . . .
boosts immunity
chronic stress . . .
suppresses immunity.
Journal Club
MDMA-assisted therapy produced greater PTSD symptom reduction vs. placebo+therapy.
CAPS-5 (measures)
PTSD severity.
SDS (measures)
disability/functional impairment.
BDI-II (measures)
depression symptoms.
Core categories of SUD symptoms
Impaired control, social impairment, risky use, tolerance, withdrawal.
General SUD mechanism
Drugs hijack reward learning systems, dopamine bursts, craving, habit circuitry.
Mesolimbic pathway
VTA, nucleus accumbens, PFC; central reward circuit using dopamine.
Craving
Intense desire driven by dopamine prediction errors and cues.
Cycle of SUD
Use, intoxication, withdrawal, craving, relapse.
Stimulants (synaptic mechanism)
increase dopamine (block reuptake or cause release).
Opioids(synaptic mechanism)
activate mu-opioid receptors, inhibit GABA, disinhibition of dopamine neurons.
Alcohol (synaptic mechanism)
enhances GABA, inhibits NMDA, increases dopamine.
Cannabinoids (synaptic mechanism)
CB1 receptor activation suppress neurotransmitter release.
Hallucinogens (synaptic mechanism)
5-HT2A agonists, altered sensory processing.
Opioid addiction treatments
methadone, buprenorphine (agonists), naltrexone (antagonist).
Alcohol addiction treatments
naltrexone, acamprosate, disulfiram.
Major depressive disorder core symptoms
Sadness, anhedonia, changes in sleep/appetite, fatigue, worthlessness, impaired concentration.
Bipolar disorder
mood disorder involving cycles of mania and depression
Bipolar I
full mania
Bipolar II
hypomania + depression.
Lithium mechanisms
Reduces excess dopamine, increases GABA, modulates second-messenger systems
Antidepressant categories
SSRIs, SNRIs, TCAs, MAOIs
TRD
Treatment resistant depression
ECT (TRD)
induces controlled seizures; very effective.
TMS (TRD)
magnetic stimulation of cortex; modulates activity.
Ketamine/esketamine (TRD)
Glutamate antagonists, rapid plasticity.
Psilocybin (TRD)
5-HT2A agonist, emotional flexibility + plasticity.
Monoamine hypothesis
Depression caused by reduced serotonin, norepinephrine, dopamine.
Other explanations for depression
Inflammation, HPA axis dysfunction, network connectivity problems, reduced plasticity.
BDNF
Brain Derived Neurotropic Factor, growth-supporting protein that helps neurons grow, survive, and form stronger connections
Neuroplasticity & BDNF
Low BDNF = reduced synaptic plasticity; antidepressants increase BDNF over time.
Diagnostic criteria schizophrenia
delusions, hallucinations, disorganized speech/behavior, negative symptoms.
Positive symptoms
things present that aren;t in normal population, like hallucinations or delusions
Negative symptoms
things missing in schizophrenia patients that are present in regular population,